The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

The systematic translation of cancer genomic data into knowledge of tumour biology and therapeutic possibilities remains challenging. Such efforts should be greatly aided by robust preclinical model systems that reflect the genomic diversity of human cancers and for which detailed genetic and pharmacological annotation is available. Here we describe the Cancer Cell Line Encyclopedia (CCLE): a compilation of gene expression, chromosomal copy number and massively parallel sequencing data from 947 human cancer cell lines. When coupled with pharmacological profiles for 24 anticancer drugs across 479 of the cell lines, this collection allowed identification of genetic, lineage, and gene-expression-based predictors of drug sensitivity. In addition to known predictors, we found that plasma cell lineage correlated with sensitivity to IGF1 receptor inhibitors; AHR expression was associated with MEK inhibitor efficacy in NRAS-mutant lines; and SLFN11 expression predicted sensitivity to topoisomerase inhibitors. Together, our results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents. The generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of ‘personalized’ therapeutic regimens.

• Publication year

  2012

• Venue

  Nature

• Publication date

  2012-03-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature11003PMID 22460905PMCID 3320027
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic identification of genomic markers of drug sensitivity in cancer cells

  2012cited by this paper
• Advances in the preclinical testing of cancer therapeutic hypotheses

  2011cited by this paper
• Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma

  2011cited by this paper
• Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma

  2011cited by this paper
• An Orally Available Small-Molecule Inhibitor of c-Met,PF-2341066,Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244).

  2010cited by this paper
• Clinical implications of the cancer genome.

  2010cited by this paper
• Molecular target class is predictive of in vitro response profile.

  2010cited by this paper
• Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

  2009cited by this paper
• Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

  2008cited by this paper
• Modeling genomic diversity and tumor dependency in malignant melanoma.

  2008cited by this paper
• Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma

  2007cited by this paper
• High-throughput oncogene mutation profiling in human cancer

  2007cited by this paper
• Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

  2007cited by this paper
• An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.

  2007cited by this paper
• Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin‐3A

  2007cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• BRAF mutation predicts sensitivity to MEK inhibition

  2006cited by this paper
• Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.

  2006cited by this paper
• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

  2005cited by this paper
• Addendum: Regularization and variable selection via the elastic net

  2005cited by this paper
• Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.

  2005cited by this paper
• Chemosensitivity prediction by transcriptional profiling

  2001cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.

  1999cited by this paper
• PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase.

  1998cited by this paper
• An Information-Intensive Approach to the Molecular Pharmacology of Cancer

  1997cited by this paper

• CHD4 epigenetically coordinates genomic instability and immunosuppression to drive pan-cancer progression and confer HDAC inhibitor sensitivity

  2026cites this paper
• AI‐Powered Framework for Evaluating Drug Efficacy for Three‐Dimensional In Vitro Cancer Models in Robot‐Assisted Production

  2026cites this paper
• Harnessing Postbiotics to Boost Chemotherapy: N-Acetylcysteine and Tetrahydro β-Carboline Carboxylic Acid as Potentiators in Pancreatic and Colorectal Cancer

  2026cites this paper
• Widespread data leakage inflates performance estimates in cancer drug response prediction

  2026cites this paper
• Systematic modeling predicts synergistic and safe drug combinations for parasitic diseases.

  2026cites this paper
• Disulfidptosis-related genes signature predicts prognosis and immune microenvironment in colon cancer

  2026cites this paper
• Gastric cancer organoids and their convergence in engineering approaches.

  2026cites this paper
• PRDX6 Modulates Immune Checkpoint Inhibitor Response by Antagonizing Ferroptosis Induced By HDAC Inhibitors

  2026cites this paper
• Drug Sensitivity Prediction Using Machine Learning on Integrated COSMIC, DGIdb, and GDSC Data

  2026cites this paper
• CLISGen: A Comprehensive Resource of SNP Genotypes for Human Cell Lines.

  2026cites this paper
• NRF2 pathway activation and SPP1⁺TREM2⁺ macrophages drive chemoradiotherapy resistance in esophageal squamous cell carcinoma

  2026cites this paper
• PLLP inhibits the progression of wild-type p53 gastric cancer by reducing p53 protein ubiquitination by binding to TRIM59.

  2026cites this paper
• VUScope: a mathematical model for evaluating image-based drug response measurements and predicting long-term incubation outcomes

  2026cites this paper
• Global mRNA 3′UTR lengthening in small-cell neuroendocrine carcinoma

  2026cites this paper
• Developing an antibody drug encapsulation nanoagent targeting HER2 for cancer treatment

  2026cites this paper
• Mechanisms of resistance to antibody-drug conjugates in breast cancer.

  2026cites this paper
• GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation

  2026cites this paper
• Defining the cellular and molecular identities of histologic subtypes in lung adenocarcinoma

  2026cites this paper
• RAD54B as a biomarker for prognosis and immunotherapy response in bladder cancer

  2026cites this paper
• AI and Big Data in Oncology: A Physician‐Centered Perspective on Emerging Clinical and Research Applications

  2026cites this paper
• UniSyn: a multi-modal framework with knowledge transfer for anti-cancer drug synergy prediction.

  2026cites this paper
• Conditionally Reprogrammed Cells Preserve Cellular Diversity and Permit Genetic Manipulation: Implications for Cancer Heterogeneity and Tissue Regeneration

  2026cites this paper
• A Pan-Cancer Single-Cell Atlas to Evaluate Tumor Identity, Cell Line Concordance, and Dependency Mapping

  2026cites this paper
• The application of experimental models for the drug discovery for digestive tumors.

  2026cites this paper
• Functional nutrient-genetic profiling reveals biotin and FBXW7 are essential to bypass glutamine addiction.

  2026cites this paper
• Development and characterization of anti-CXCR4 chimeric antigen receptor T cells.

  2026cites this paper
• Circadian rhythm heterogeneity modulates drug response variations in neuroblastoma models.

  2026cites this paper
• Importance of genetic ancestry in pharmacogenomics for precision medicine.

  2026cites this paper
• GATRSyn: Advancing Anticancer Drug Synergy Prediction Through Graph Attention Networks and Transformer-based Feature Re-embedding.

  2026cites this paper
• Keratinization-related gene signature predicting survival and response to radiation in patients with HPV-negative head and neck squamous cell carcinoma via regulation of cornification and integrin signaling

  2026cites this paper
• DeepKGI: Cross-layer graph fusion and interpretable key gene identification for cancer drug response prediction

  2026cites this paper
• Ginsenoside Rh3 enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway.

  2026cites this paper
• KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition.

  2026cites this paper
• ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia

  2026cites this paper
• Semantic-enhanced heterogeneous graph learning for identifying ncRNAs associated with drug resistance

  2026cites this paper
• Low tumoral Trefoil Factor 1 expression relates to aggressive tumor features and poor survival in young women with breast cancer

  2026cites this paper
• FBApro: A fast, simple linear transformation for diverse metabolic modeling tasks

  2026cites this paper
• Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populations.

  2026cites this paper
• Schlafen 5 is an intracellular immune checkpoint and controls interferon responses in pancreatic ductal adenocarcinoma.

  2026cites this paper
• Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia.

  2026cites this paper
• Clinical Efficacy and Safety Assessment of Specific-Mode Electroacupuncture Stimulation Combined With Paclitaxel for Recurrent Malignant Gliomas: Study Protocol for a Single-Arm Trial

  2026cites this paper
• Benchmarking deep learning models for predicting anticancer drug potency (IC50) with insights for medicinal chemists

  2026cites this paper
• Human hepatic cell line 5: In-vitro model for hepatic immunobiology

  2026cites this paper
• MTEGDRP: Interpretable Molecular Self-Attention Transformer and Equivariant Graph Neural Network Based on Multi-Omics Fusion for Drug Response Prediction in Cancer Cell Lines.

  2026cites this paper
• TCN-5mC: a predictor of 5-methylcytosine sites based on multi-feature fusion and TCN-inspired block networks

  2026cites this paper
• RBM47-Induced Gasdermin A/GSDMA Mediates Mesenchymal–Epithelial Transition and Pyroptosis of Colorectal Cancer Cells

  2026influential citation
• TiRank prioritizes phenotypic niches in tumor microenvironment for clinical biomarker discovery

  2026cites this paper
• Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis

  2026cites this paper
• The aryl hydrocarbon receptor (AHR) drives human leukocyte antigen (HLA)-II expression in human melanoma.

  2026cites this paper
• Large-scale mapping of environmental-genetic interactions illustrates the dynamic nature of cell-cycle and DNA repair regulation.

  2026cites this paper
• ASH2L induces tamoxifen resistance via H3K4me3 dependent ITGA6/ERK signaling in ER-positive breast cancer.

  2026cites this paper
• A disease model resource reveals core principles of tissue-specific cancer evolution.

  2026cites this paper
• Domain-adaptation deep learning models do not outperform simple baseline models in single-cell anti-cancer drug sensitivity prediction

  2026cites this paper
• AMDRP: adaptive drug feature fusion and multihead bidirectional cross-attention network for drug-cancer cell response prediction.

  2026cites this paper
• Sortilin exhibits tumor suppressor-like activity by limiting EGFR transduction function

  2026cites this paper
• Development and In vitro antitumor evaluation of a novel anti-p16 antibody fragment-drug conjugate.

  2026cites this paper
• Systematic cysteine scanning identifies a druggable pocket in oncogenic KRAS.

  2026cites this paper
• Precision oncology in a dish: patient-derived glioma organoids to guide novel therapeutic strategies

  2026cites this paper
• scLong: a billion-parameter foundation model for capturing long-range gene context in single-cell transcriptomics.

  2026cites this paper
• Systems-level analysis identifies IRF6 as an inhibitor of epithelial-mesenchymal transition

  2026cites this paper
• Drug Sensitivity Prediction Across Cancer Cell Lines with a Focus on Sarcoma

  2026cites this paper
• Targeting glycerophospholipid biosynthesis overcomes chemoresistance driven by SLFN11 loss in Ewing sarcoma

  2026cites this paper
• p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

  2026cites this paper
• PARP1 Suppression Drives ROS Resistance in Aneuploid Cancer Cells

  2026cites this paper
• Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer

  2026cites this paper
• Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cells

  2026cites this paper
• scXDR: drug response prediction across single-cell datasets via heterogeneous network transfer learning

  2026cites this paper
• A patent review of KDM4 histone demethylase inhibitors (2014-present)

  2026cites this paper
• Pan-cancer RNA editing activity reveals complex editing functions and cancer immunotherapy biomarkers

  2026cites this paper
• Establishment of an amino acid metabolism related signature for prognostic and therapeutic sensitivity prediction in breast cancer by machine learning

  2026cites this paper
• Computational frameworks for enhanced extracellular vesicle biomarker discovery

  2026cites this paper
• In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment.

  2026cites this paper
• FACS-based genome-wide CRISPR screening platform identifies modulators of CD47

  2026cites this paper
• Nuclear gasdermin E drives endothelin-1-induced metastatic progression independently of the pyroptosis

  2026cites this paper
• Genomic language model mitigates chimera artifacts in nanopore direct RNA sequencing

  2026cites this paper
• An expanded role for single-cell chemical genomics profiling in drug discovery

  2026cites this paper
• Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.

  2026cites this paper
• Pathogenomic analysis reveals clinically relevant epithelial-mesenchymal plasticity in esophageal squamous cell carcinoma

  2026cites this paper
• Effect of chemoradiation treatment on methylated BCAT1 and IKZF1 in rectal cancer.

  2026cites this paper
• Common gene mutations in 103 authenticated colorectal cancer cell lines

  2026influential citation
• SOLVE: A structured orthogonal latent variable framework for disentangling confounding in matrix data

  2026cites this paper
• Cycling molecular assemblies for Golgi imaging and disruption

  2026cites this paper
• SensitiveCancerGPT: Leveraging Generative Large Language Model on Structured Omics Data to Optimize Drug Sensitivity Prediction

  2025influential citation
• Integrating gene expression, mutation and copy number data to identify driver genes of recurrent chromosome-arm losses

  2025cites this paper
• High levels of DNA replication initiation factors indicate ATRi sensitivity via excessive origin firing

  2025cites this paper
• Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer

  2025cites this paper
• Genomic alterations in the WNT/β-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapies

  2025cites this paper
• Utility of a Large Series of B‐Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System

  2025cites this paper
• XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells

  2025cites this paper
• Multilevel classification framework for breast cancer cell selection and its integration with advanced disease models

  2025cites this paper
• Predicting gene essentiality and drug response from perturbation screens in preclinical cancer models with LEAP: Layered Ensemble of Autoencoders and Predictors

  2025cites this paper
• Circadian clock features define novel subtypes among breast cancer cells and shape drug sensitivity

  2025cites this paper
• Comprehensive Multi-Omics Analysis Identifies FUT1 as a Prognostic and Therapeutic Biomarker Across Pan-Cancer

  2025cites this paper
• Systematic identification of cancer pathways and potential drugs for intervention through multi-omics analysis

  2025cites this paper
• A pan-cancer analysis of the oncogenic and immunological roles of RGS5 in clear cell renal cell carcinomas based on in vitro experiment validation

  2025cites this paper
• Identification of KCNJ5 gene an adverse prognosis associated novel onco-ionchannel in Indian pancreatic cancer cohort

  2025cites this paper
• GRNFormer: A Biologically-Guided Framework for Integrating Gene Regulatory Networks into RNA Foundation Models

  2025cites this paper
• Single Cell Inference of Cancer Drug Response Using Pathway‐Based Transformer Network

  2025cites this paper
• ImmunoMatch learns and predicts cognate pairing of heavy and light immunoglobulin chains

  2025cites this paper
• Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells

  2025cites this paper